Read More Pharma Industry News Novo Nordisk acquires Ziylo in $800m deal to advance diabetes treatment Novo Nordisk, a leading Danish pharmaceutical company, has completed a significant acquisition of Ziylo, a biotechnology spin-out from… bySrinathAugust 24, 2018
